Found: 35
Select item for more details and to access through your institution.
Endocrinopathies and the skin.
- Published in:
- International Journal of Dermatology, 2000, v. 39, n. 2, p. 88, doi. 10.1046/j.1365-4362.2000.00874.x
- By:
- Publication type:
- Article
Cutaneous Manifestations of Endocrine Disorders: A Guide for Dermatologists.
- Published in:
- American Journal of Clinical Dermatology, 2003, v. 4, n. 5, p. 315, doi. 10.2165/00128071-200304050-00003
- By:
- Publication type:
- Article
Insulin resistance, diabetes and cardiovascular risk: approaches to treatment.
- Published in:
- Diabetes, Obesity & Metabolism, 2005, v. 7, n. 6, p. 642, doi. 10.1111/j.1463-1326.2004.00446.x
- By:
- Publication type:
- Article
Co‐shared genetics and possible risk gene pathway partially explain the comorbidity of schizophrenia, major depressive disorder, type 2 diabetes, and metabolic syndrome.
- Published in:
- American Journal of Medical Genetics. Part B: Neuropsychiatric Genetics, 2019, v. 180, n. 3, p. 186, doi. 10.1002/ajmg.b.32712
- By:
- Publication type:
- Article
Sodium‐glucose co‐transporter‐2 inhibitors in patients with type 2 diabetes: Barriers and solutions for improving uptake in routine clinical practice.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1187, doi. 10.1111/dom.14684
- By:
- Publication type:
- Article
Efficacy and safety of dapagliflozin plus saxagliptin versus insulin glargine over 52 weeks as add‐on to metformin with or without sulphonylurea in patients with type 2 diabetes: A randomized, parallel‐design, open‐label, Phase 3 trial
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 6, p. 957, doi. 10.1111/dom.13981
- By:
- Publication type:
- Article
Exenatide and dapagliflozin combination improves markers of liver steatosis and fibrosis in patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 3, p. 393, doi. 10.1111/dom.13907
- By:
- Publication type:
- Article
Hormone‐substrate changes with exenatide plus dapagliflozin versus each drug alone: The randomized, active‐controlled DURATION‐8 study.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 1, p. 99, doi. 10.1111/dom.13870
- By:
- Publication type:
- Article
Effect of exenatide QW or placebo, both added to titrated insulin glargine, in uncontrolled type 2 diabetes: The DURATION‐7 randomized study.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 7, p. 1602, doi. 10.1111/dom.13266
- By:
- Publication type:
- Article
Effects of exenatide once weekly plus dapagliflozin, exenatide once weekly alone, or dapagliflozin alone added to metformin monotherapy in subgroups of patients with type 2 diabetes in the DURATION‐8 randomized controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 6, p. 1520, doi. 10.1111/dom.13296
- By:
- Publication type:
- Article
Effects of exenatide once weekly plus dapagliflozin, exenatide once weekly, or dapagliflozin, added to metformin monotherapy, on body weight, systolic blood pressure, and triglycerides in patients with type 2 diabetes in the DURATION‐8 study.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 6, p. 1515, doi. 10.1111/dom.13206
- By:
- Publication type:
- Article
Recent trends in the prevalence of type 2 diabetes and the association with abdominal obesity lead to growing health disparities in the USA: An analysis of the NHANES surveys from 1999 to 2014.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 3, p. 667, doi. 10.1111/dom.13143
- By:
- Publication type:
- Article
Dapagliflozin in patients with type 2 diabetes mellitus: A pooled analysis of safety data from phase IIb/III clinical trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 3, p. 620, doi. 10.1111/dom.13124
- By:
- Publication type:
- Article
Safety and efficacy of IDegLira titrated once weekly versus twice weekly in patients with type 2 diabetes uncontrolled on oral antidiabetic drugs: DUAL VI randomized clinical trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 6, p. 858, doi. 10.1111/dom.12892
- By:
- Publication type:
- Article
Physicians' Considerations and Practice Recommendations Regarding the Use of Sodium-Glucose Cotransporter-2 Inhibitors.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 20, p. 6051, doi. 10.3390/jcm11206051
- By:
- Publication type:
- Article
Erratum to: Musculoskeletal manifestations of primary hyperparathyroidism.
- Published in:
- 2017
- By:
- Publication type:
- Erratum
Musculoskeletal manifestations of primary hyperparathyroidism.
- Published in:
- Clinical Rheumatology, 2016, v. 35, n. 12, p. 3081, doi. 10.1007/s10067-016-3450-3
- By:
- Publication type:
- Article
Accuracy of bedside capillary blood glucose measurements in critically ill patients.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Insulin Degludec 200 Units/mL Is Associated With Lower Injection Frequency and Improved Patient-Reported Outcomes Compared With Insulin Glargine 100 Units/mL in Patients With Type 2 Diabetes Requiring High-Dose Insulin.
- Published in:
- Clinical Diabetes, 2017, v. 35, n. 2, p. 90, doi. 10.2337/cd15-0058
- By:
- Publication type:
- Article
Skin manifestations of hormone-secreting tumors Jabbour Hormone-secreting tumors.
- Published in:
- Dermatologic Therapy, 2010, v. 23, n. 6, p. 643, doi. 10.1111/j.1529-8019.2010.01369.x
- By:
- Publication type:
- Article
Effect of Oral Semaglutide Compared With Placebo and Subcutaneous Semaglutide on Glycemic Control in Patients With Type 2 Diabetes: A Randomized Clinical Trial.
- Published in:
- JAMA: Journal of the American Medical Association, 2017, v. 318, n. 15, p. 1460, doi. 10.1001/jama.2017.14752
- By:
- Publication type:
- Article
Correction to: Safety and Efficacy of Exenatide Once Weekly in Participants with Type 2 Diabetes and Stage 2/3 Chronic Kidney Disease.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Safety and Efficacy of Exenatide Once Weekly in Participants with Type 2 Diabetes and Stage 2/3 Chronic Kidney Disease.
- Published in:
- Diabetes Therapy, 2020, v. 11, n. 7, p. 1467, doi. 10.1007/s13300-020-00815-z
- By:
- Publication type:
- Article
Herpes Zoster Incidence and Burden in Adults With Type 2 Diabetes in the U.S.: A Retrospective Database Analysis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Efficacy and Safety Over 2 Years of Exenatide Plus Dapagliflozin in the DURATION-8 Study: A Multicenter, Double-Blind, Phase 3, Randomized Controlled Trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Dapagliflozin Plus Saxagliptin Add-on Therapy Compared With Insulin in Patients With Type 2 Diabetes Poorly Controlled by Metformin With or Without Sulfonylurea Therapy: A Randomized Clinical Trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Safety and Efficacy of Exenatide Once Weekly Plus Dapagliflozin Once Daily Versus Exenatide or Dapagliflozin Alone in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy: 52-Week Results of the DURATION-8 Randomized Controlled Trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Dapagliflozin Is Effective as Add-on Therapy to Sitagliptin With or Without Metformin: A 24-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study.
- Published in:
- Diabetes Care, 2014, v. 37, n. 3, p. 740, doi. 10.2337/dc13-0467
- By:
- Publication type:
- Article
Working up the thyroid nodule.
- Published in:
- Patient Care (Print), 2005, v. 39, n. 1, p. 24
- By:
- Publication type:
- Article
Ovarian Leydig Cell Hyperplasia: An Unusual Case of Virilization in a Postmenopausal Woman.
- Published in:
- 2014
- By:
- Publication type:
- Case Study
71-LB: Meta-analysis of Two Real-World Chart Review Studies to Determine the Effectiveness of FreeStyle Libre Flash Glucose Monitoring System on HbA1c in Adults with Type 2 Diabetes Managed with Basal Insulin.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-71-LB
- By:
- Publication type:
- Article
64-LB: Glucose Control after Initiation of Flash Glucose Monitoring in Type 2 Diabetes Managed with Basal Insulin: A Retrospective Real-World Chart Review Study from the U.S.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-64-LB
- By:
- Publication type:
- Article
184-LB: Incidence of Herpes Zoster in Patients with Type 2 Diabetes and Consequences for Treatment.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-184-LB
- By:
- Publication type:
- Article
2302-PUB: Exenatide Once-Weekly in Diabetes Patients with Stage 2/3 Chronic Kidney Disease—A Pooled 6-Month Analysis.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-2302-PUB
- By:
- Publication type:
- Article